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Abstract
Charcot–Marie–Tooth type 4B1 (CMT4B1) is an autosomal recessive motor and sensory demyelinating neuropathy characterized by the
association of early-onset neurological symptoms and typical histological findings. The natural history and the clinical variability of the disease
are still poorly known, thus further clarification of the different phenotypes is needed. We report on the case of a Pakistani girl born to
consanguineous parents harboring a novel mutation in the MTMR2 gene. When aged 18 months, reduced limb tone, muscle wasting associated with
proximal and distal weakness prevalent in lower limbs, absence of tendon reflexes, hoarseness and inspiratory stridor were detected. Vocal cord
palsy was diagnosed shortly after. We suggest that laryngeal involvement might be a relevant and initial feature of early-onset CMT4B1
neuropathy. Thus, affected patients should undergo early laryngological evaluation in order to prompt an appropriate management.
© 2017 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/
by/4.0/).
Keywords: CMT4B1; MTMR2; Vocal cord palsy; Autosomal recessive neuropathy; Vocal fold laterofixation
1. Introduction
Charcot–Marie–Tooth neuropathy (CMT) represents a
widely heterogeneous group of disorders with a broad spectrum
of clinical and electrophysiological features. More than 80
genes have been identified so far as responsible for CMT,
including dominant, recessive and X-linked forms [1].
CMT type 4B1 (CMT4B1) is an autosomal recessive (AR)
motor and sensory demyelinating neuropathy characterized by
the association of early-onset neurological symptoms and
typical biopsy findings. The histopathological hallmark is the
presence of myelin outfoldings in the nerve, redundant and
irregular loops of myelin around the axon [2]. The disease is
caused by loss-of-function mutations in the Myotubularin-
related 2 gene (MTMR2) on chromosome 11q22 [3].
To date, few cases have been reported and further
clarification of the different phenotypes associated with this
gene is needed, particularly in consideration of the poor
knowledge on the natural history of the disease and its severe
course, which may need to provide clinical warnings to
care-givers.
We here report the case of a patient with a novel mutation in
the MTMR2 gene, who started to experience stridor and was
diagnosed with bilateral vocal cord paralysis at the age of 18
months.
2. Case report
2.1. Clinical and electrophysiological phenotype
The proband is a Pakistani girl born to consanguineous
parents (first cousins) after uneventful pregnancy (February
2013). Pes planus was present at birth and she started to walk
unaided at 16 months. In the family history, a first-degree
cousin experienced early walking difficulties and hoarseness,
* Corresponding author. Department of Neurology, San Raffaele Scientific
Institute, Via Olgettina 60, 20132 Milan, Italy. Fax: +39 02 2643 5093.
E-mail address: zambon.alberto@hsr.it (A.A. Zambon).
http://dx.doi.org/10.1016/j.nmd.2017.01.006
0960-8966/© 2017 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/
4.0/).
Available online at www.sciencedirect.com
Neuromuscular Disorders 27 (2017) 487–491
www.elsevier.com/locate/nmd
ScienceDirect
and died at age of 9 years of respiratory failure, while still
ambulant [Pedigree is reported in Fig. 1].
Our patient underwent orthopedic assessment at the age of
12 months and was then evaluated by a neurologist at 18
months. Neurological examination revealed bilateral facial
weakness, reduced limb tone, muscle wasting prevalent in lower
limbs, absence of tendon reflexes, proximal and distal weakness
prevalent in lower limbs, hoarseness and inspiratory stridor. No
palpable nerves were noted. Electrophysiological studies
performed at 25 months revealed severe motor-sensory
demyelinating neuropathy with secondary axonal loss [Ulnar
nerve motor conduction velocity (CV) 27.1 m/s, CMAP 2 mV;
Peroneal nerve motor CV 17.3 m/s, CMAP 0.4 mV; Median
nerve sensory CV 19.4 m/s, SAP 2.8 μV; Sural nerve SAP not
evocable].
In the following months neurological symptoms did not
significantly evolve but the patient continued to present labored
respiration with mild stridor. In January 2015 she underwent
examination of the larynx by flexible videolaryngoscopy. The
exam revealed left vocal cord palsy with right-sided
hypomobility. Due to potential complication related to vocal
cord paralysis, including respiratory insufficiency with possible
aspiration and bronchopneumonia, the patient was considered a
candidate for tracheostomy. However, considering the lack of
progression of laryngeal symptoms in the following year and
the presence of a normal polysomnography performed at 32
months [Oxygen desaturation events index (n°/h): 0.8.
Minimum SatO2% value: 90, Mean SatO2% value: 94], surgical
intervention was not performed and a regular follow-up was
scheduled. Her laryngeal motility disorder was monitored by
Fig. 1. Molecular analysis and nerve biopsy. (a) Pedigree of the reported family with two affected individuals, first cousins. (b) Electropherograms of exon 6 of the
MTMR2 gene show that the c.484 C>T (p.Arg162*) mutation is present in heterozygosity in the unaffected parents and in homozygosity in the proband (IV, 5). The
asterisk in the electropherograms indicates the mutation. (c) Sural nerve biopsy of the proband revealed the presence of fibers with outfoldings, infoldings and with
redundant basal lamina (arrow). Bar is 1 μm.
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flexible videolaryngoscopies performed at intervals of 3–4
months. A progressive respiratory deterioration was observed
with constant stridor for every minimal effort, activation of
accessory respiratory muscles and inspiratory chest retractions,
restlessness and difficulties during feeding. At the age of 3
years and 4 months a complete bilateral laryngeal paralysis was
observed, with vocal cords in adduction and a respiratory space
of about 1 mm. The parents refused surgical treatment at that
time. At the age of 3 years and 7 months, due to worsening of
clinical symptoms after an upper airway infection with severe
respiratory obstruction, the patient required treatment in the
Intensive Care Unit. Before admission the child was still able to
walk unassisted with bilateral foot-drop and in the previous
weeks she had started to present occasional dysphagia for both
liquid and solid food. Muscle strength measured by MRC was
3–4 proximally in upper and lower limbs, 1–2 in the anterior
tibialis and peroneus muscles. First, we performed glottic
enlargement by direct microlaryngoscopy as an attempt to
avoid permanent tracheotomy. After deep sedation, the vocal
cords widely opened suggesting that the activity of vocal cords
adductor muscles was a possible co-factor of the severe glottic
obstruction. After incision of the mucosal surface of the
posterior right vocal cord by CO2 laser, we partially vaporized
the vocal muscle. Then, we placed two endo-extralaryngeal
sutures by Lichtenberger needle carrier [4] in order to achieve
lateralization of the posterior third of the vocal cord and to
obtain closure of the cordotomy wound. We obtained the
widening of the glottic space and extubated the child, who
showed progressive respiratory improvement. A week after
first surgery, the patient underwent tracheotomy as stridor had
fully recurred and severe respiratory effort was persisting.
Videolaryngoscopy showed the recurrence of glottic
obstruction due to active adduction of the arytenoids during the
whole respiratory cycle. After tracheotomy the child showed a
general health improvement and resumed oral feeding.
2.2. Nerve biopsy and molecular findings
Sequencing analysis was initially performed in the GDAP1
gene, responsible for autosomal recessive CMT4A and
frequently associated with vocal cord paresis and stridor. As no
mutations were detected, sural nerve biopsy was carried out at
20 months of age. Morphological analysis revealed reduced
fiber number, several fibers with reduced myelin thickness, rare
onion bulbs and the presence of abundant myelin outfoldings
(Fig. 1), which are a hallmark of CMT4B neuropathy. Given the
early onset of the neuropathy, MTMR2 was first analyzed by
performing Sanger sequencing analysis and a novel nonsense
mutation in exon 6c.484 C>T; p.Arg162* was found.
Consistent with an autosomal recessive inheritance, this
mutation was present in homozygosity in the proband whereas
unaffected parents were both heterozygous carriers of the
mutation. This variant was not reported in the SNP database
(dbSNP build 132, http://www.ncbi.nlm.nih.gov/projects/SNP)
or in 1000 Genomes (www.1000genomes.org). The premature
truncation of the MTMR2 protein at codon 162 leads to the
deletion of part of the RID domain, the entire PTP-like
phosphatase domain and the CC (coiled-coil) C-terminal motif
[5,6]. Moreover, mutations in the MTMR13 gene responsible
for CMT4B2, a severe early onset demyelinating neuropathy
also characterized by myelin outfoldings in the nerve, were
excluded in the proband as well.
3. Discussion
ARCMTs are usually associated with more severe phenotypes
as compared to dominant forms [7]. Along with motor and
sensory defects, they usually present earlier onset and more
marked distal limb deformities, sometimes associated with
major spinal abnormalities and other complications. Among
CMT-associated complications, vocal cord paralysis is still an
underestimated finding. Vocal cord paralysis has been reported
as an early, severe and frequent symptom of GDAP1-associated
neuropathy [CMT4A], often followed by diaphragmatic
dysfunction [8–13], and in both AD and AR forms of CMT2A
(mutations in the MFN2 gene) [14,15]. Few cases are reported
in axonal dominant CMT2C (mutations in the transient receptor
potential cation channel, subfamily V, member 4; TRPV4)
[16–18] and as a later involvement in a patient harboring a
dominant heterozygous mutation of early growth response 2
(EGR2) gene [19]. Rarely, it has been associated with other
variants and polymorphisms [20–24].
An overview of all previously reported cases with early
onset in life is provided in Table 1.
Regarding CMT4B1, vocal cord paralysis was reported in
one Italian patient, one English patient, and three Algerian
siblings by Sabatelli [25], Tyson and Houlden [26,27] and
Nouioua [28], respectively. All of the patients suffered from
early-onset (1–2 years-old) severe demyelinating neuropathy
associated with respiratory difficulties. The Algerian siblings
presented prominent chest deformities possibly secondary to
breathing impairment. In the latter cases sequencing analysis
revealed mutations located in exon 4 (c.G308A; p.Gly103Glu
and c.331dupA; p.Arg111LysfsX24, respectively). Notably,
laryngeal involvement was present in early stages of the disease
in all cases.
In our patient, vocal cord paralysis presented as an early
symptom, as the onset was between 1 and 2 years of age. The
vocal cord disease manifested as a hoarse voice and stridor,
associated with the use of accessory inspiratory muscles. An
asymmetric involvement of vocal cords was initially noticed
with a more severe paralysis of the left cord. This finding was
present in previous reports [8,20] and it has been interpreted as
a sign of length-dependent degeneration of the neuropathy.
However, initial paralysis of the right vocal cord is reported as
well and usually a progression toward bilateral deficit is
observed. Most of the genes involved in vocal cord paralysis
encode for proteins playing a role also in neurons. We may
speculate that vocal cord paralysis results from neuronal
dysfunction in the bulbar nucleus of the recurrent nerve, rather
than a consequence of a length-dependent neuropathy. This
might also explain why only few CMT subtypes develop this
complication and why no clear correlation with the severity of
neuropathy is observed.
To our knowledge, no progression to respiratory failure was
seen in previously reported cases. The patient reported by Tyson
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and colleagues, when aged 16, began to develop frequent chest
infections and nocturnal hypoventilation. He was started on a
nighttime BIPAP facial mask ventilator with resolution of
symptoms. Nevertheless, as shown by our proposita,
progressive laryngeal involvement may cause life-threatening
airway obstruction, aspiration and pneumonia. Decreased life
expectancy and premature death, which was previously
described in other forms of CMT [5,8], was observed also in
our patient’s first cousin, who was likely to harbor the same
gene mutation (see genetic pedigree) and died of sudden death
due to upper airway involvement at the age of 9, while he was
still able to walk unaided.
In conclusion, we suggest that the finding of bilateral
laryngeal paralysis or hypomotility due to unknown causes
should prompt a warning for a neuromuscular disorder, notably
a hereditary neuropathy, and help the physician to target
molecular investigations. Particularly, we feel that laryngeal
involvement might be a relevant and initial finding in
Table 1
Clinical reports of CMT cases associated with laryngeal involvement in the first 2 decades.
Reference Gender/number
of patients
(age)
Country of
origin
Age of
walking
(months)
Age of
onset
Age of VF
involvement
Cranial nerve
involvement
Other peculiar features Loss of
ambulation
(age)
Gene CMT type, mode
of inheritance
Present case F/1 (3y) Pakistan 16 12–18m 18m Bilateral facial
paresis, mild
dysphagia
Pes planus Still
walking
MTMR2 CMT4B1, AR
Sabatelli et al.,
1994
Luigetti et al.,
2013
F/1 (28y) Italy 13 14–15m 15m Dysphagia,
weakness of
masticatory muscles,
facial paresis
NA 22y MTMR2 CMT4B1, AR
Tyson et al., 1997 M/1 (16y) England 13 13–36m 36m Difficulty with
phonation, chewing,
swallowing
Diaphragm paresis 16y MTMR2 CMT4B1, AR
Nouioua et al.,
2011
M/3 (8-16y) Algeria NA 1–2y Stridor
present
at onset
Facial paresis Chest deformities +++
Breathing difficulties.
Pes equinovarus, claw
hands
Still
walking
MTMR2 CMT4B1, AR
Dyck et al., 1994 F/2 (26-47y) NA NA 6–8m 6-8m Congenital III
cranial nerve palsy
Short stature, diaphragm
paresis
NA TRPV4 CMT2C, AD
Chen et al., 2010 F/3 (44-73y);
M/1 (29y)
Non-Hispanic
white
American
NA 1–10y 1-10y NA Short stature, diaphragm
paresis
NA TRPV4 CMT2C, AD
Echaniz-Laguna
et al., 2014
M/10; F/7 France, Italy,
Greece
NA Childhood NA Hearing loss Kyphoscoliosis,
hyperCKemia, scapular
winging, respiratory
insufficiency, skeletal
dysplasia,
arthrogryposis, postural
tremor
Still
walking
TRPV4 CMT2C; CSMAA;
dHMN ; SPSMA;
AD – de novo
-incomplete
penetrance
Borkoel et al.,
2003
F/1 (34y); M/1
(64y)
Japan; Costa
Rica
15; 36 2y; 6m NA Facial paresis;
dysphagia
NA NA GDAP1 CMT4A, AR
Sevilla et al., 2003 M/8; F/1
(33-57y)
France 12–18 Birth–2y late NA NA 9y; 12y;
30y
GDAP1 CMT4A, AR
Azzedine et al.,
2003
M/1 (30y) Morocco Normal 3y 20y NA Paralysis of one hemi
diaphragm
15y GDAP1 CMT4A, AR
Stojkovic et al.,
2004
F/2 (32-33y) France 20 <2 y early in life NA Diaphragm paresis 25y GDAP1 CMT4A, AR
Sevilla et al, 2008 M/6; F/3
(16-49y)
Spain 12–18 <1y–8y NA Bilateral facial
weakness (n° 1);
dysphagia (n° 1)
Diaphragm paresis 9- 38y
(median 16)
GDAP1 CMT4A, AR
Moroni et al.,
2009
M/1 (16y); F/1
(11y)
Italy 12–18 2y 13y NA NA 12y; still
walking
GDAP1 CMT4A, AR
McEntagart et al.,
2001 [30]
M/13; F/8 Wales NA 2nd decade 2nd decade NA Distal muscular atrophy NA Dynactin dHMN-VII, AD
Polke et al., 2011 F/1 (39y) Italy NA 3y NA Severe facial
weakness, hearing
loss, visual loss
Kyphoscoliosis,
respiratory muscles
weakness
Wheelchair
(age not
known)
MFN2 CMT2, AR
Bombelli et al.,
2014
6 NA NA Early onset NA NA Severe disability (5/6) NA MFN2 CMT2, AD
Pehlivan et al.,
2015 [31]
M/1 († 33 m) Turkey Not
acquired
<6m <6m NA Lateral knee
contractures,
hammer toes, pes
equinus and pes cavus
NA TRIM2 AR
Abbreviations: AD, autosomal dominant; AR, autosomal recessive; CMT, Charcot–Marie–Tooth; CSMAA, congenital spinal muscular atrophy and arthrogryposis; dHMN, distal hereditary
motor neuropathy; F, female; GDAP1, ganglioside-induced differentiation-associated protein 1; m, months; M, male; MFN2, mitofusin-2; MTMR2, myotubularin related protein 2; NA:
data not available; SPSMA, scapula-peroneal spinal muscular atrophy; TRIM2, tripartite motif containing 2; TRPV4, transient receptor potential cation channel subfamily V member 4; VF,
vocal fold; y, years; †, died.
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early-onset CMT4B1 neuropathy and thus all the patients
with positive molecular genetics for MTMR2 should be
promptly investigated for laryngeal function. Periodic
videolaryngoscopic follow-up is mandatory in patients with a
CMT subtype associated with vocal cord paralysis in order to
detect possible vocal cord hypomotility and to quantify the
degree of airway obstruction. It is known that a young child can
tolerate without symptoms a laryngotracheal obstruction up to
70% of the lumen, and that a slowly progressing obstruction
may manifest with moderate stridor up to 80% or more [29].
Nevertheless, in such a clinical condition even a mild upper
airway infection might have lethal consequences. Severe chest
retractions, failure to thrive, refusal of food and no interest in
playing might all be the signs of a critical condition which
might rapidly precipitate [29]. Parents of the child should be
made aware of their child condition in order to seek for hospital
assistance as soon as they notice worsening of respiratory
distress. In the described case, a first attempt to achieve a wider
glottic space was performed by a vocal cord laterofixation
procedure; this is a conservative mean of widening the posterior
glottis respecting both phonatory and sphincteric functions of
the larynx. Nevertheless, this procedure did not work in our
patient, possibly due to the neuropathy as pathogenic
mechanism of the vocal cord paralysis. Moreover, this case
showed the role of active contraction of vocal cord adductor
muscles as a cause of laryngeal obstruction in CMT patients.
Tracheotomy appears then to be a necessary procedure to
relieve the respiratory distress in patients affected by bilateral
laryngeal paralysis in CMT.
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